Adilson Joaquim Westheimer Cavalcante

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

Covid-19 Pandemic, Respiratory Infection, Infectious Respiratory Disease +6

A multicenter study using positive deviance for improving hand hygiene compliance

Alexandre R. Marra, Danilo Teixeira Noritomi, Adilson Joaquim Westheimer Cavalcante et al. · American Journal of Infection Control · 2013 · 66 citations

Behavioral Sciences, Health Promotion, Hand Hygiene Compliance +6

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair et al. · EClinicalMedicine · 2024 · 24 citations · Full text

Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

Huijie Bian, Liang Chen, Zhaohui Zheng et al. · Signal Transduction and Targeted Therapy · 2023 · 16 citations · Full text